Abstract
Background
The invasive behaviour of squamous cell carcinoma (SCC), a common malignant tumour of the mouth, is a process mediated by cell proliferation, extracellular matrix proteolysis and other factors. Studies have shown a potential relationship between growth factors, metallothionein 2A (MT2A) and matrix metalloproteinase (MMP) activation in malignant tumours. The aim of this study was to downregulate MT2A in cells (Cal27) derived from human squamous cell carcinoma.
Methods
Cal27 cells with reduced MT2A were subjected to proliferation, migration and invasion assays. Immunofluorescence and western blot confirmed MT2A depletion by siRNA. Growth curve assays assessed cell proliferation. Indirect immunofluorescence analysed the expression of MT2A, MMP-2, MMP-9, epidermal growth factor (EGF), transforming growth factor alpha (TGF-α), tumour necrosis factor alpha (TNF-α) and Ki67. Zymography evaluated the effects of MT2A silencing on MMP-2 and -9 expression. Migration and invasion activities were evaluated using migration and invasion assays.
Results
CAL27 cells displayed MT2A, MMP-2, MMP-9, EGF, TGF-α, TNF-α and Ki67. MT2A depletion decreased MMP-9, EGF, TGF-α and Ki67 protein levels, while increasing TNF-α.
Conclusions
MT2A downregulation reduced cell proliferation, migration and invasion activities. Therefore, MT2A has an important role in cell proliferation, migration and invasion in human oral SCC cells.
Similar content being viewed by others
Data Availability
The datasets generated or analysed during the current study are available from the corresponding author on reasonable request. Supplementary information is available for this paper (see Supplementary Information file).
Abbreviations
- EGF:
-
Epidermal growth factor
- ECM:
-
Extracellular matrix
- FBS:
-
Foetal bovine serum
- MMP:
-
Matrix metalloproteinase
- MT:
-
Metallothionein
- MT2A:
-
Metallothionein 2A
- SCC:
-
Squamous cell carcinoma
- TGF-α:
-
Transforming growth factor alpha
- TNF-α:
-
Tumour necrosis factor alpha
References
El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (2017) World health organisation classification of head and neck tumours, 4th edn. IARC Press, Lyon
Pereira AL, Veras SS, Silveira EJ, Seabra FR, Pinto LP, Souza LB et al (2005) The role of matrix extracellular proteins and metalloproteinases in head and neck carcinomas: an updated review. Braz J Otorhinolaryngol 71(1):81–86. https://doi.org/10.1016/s1808-8694(15)31289-1
Salomon DS, Brandt R, Ciardiello F, Normanno N (1995) Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol 19(3):183–232. https://doi.org/10.1016/1040-8428(94)00144-i
Myoung H, Kim MJ, Lee JH, Ok YJ, Paeng JY, Yun PY (2006) Correlation of proliferative markers (Ki-67 and PCNA) with survival and lymph node metastasis in oral squamous cell carcinoma: a clinical and histopathological analysis of 113 patients. Int J Oral Maxillofac Surg 35(11):1005–1010. https://doi.org/10.1016/j.ijom.2006.07.016
Coutinho-Camillo CM, Lourenço SV, Nishimoto IN, Kowalski LP, Soares FA (2010) Nucleophosmin, p53, and Ki-67 expression patterns on an oral squamous cell carcinoma tissue microarray. Hum Pathol 41(8):1079–1086. https://doi.org/10.1016/j.humpath.2009.12.010
van Horssen R, Ten Hagen TL, Eggermont AM (2006) TNF-alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility. Oncologist 11(4):397–408. https://doi.org/10.1634/theoncologist.11-4-397
Ribeiro AL, Nobre RM, Rocha GC, de Souza Lobato IH, de Melo Alves Junior S, Jaeger RG, et al (2011) Expression of metallothionein in ameloblastoma. A regulatory molecule? J Oral Pathol Med 40(6):516–519. https://doi.org/10.1111/j.1600-0714.2011.01025.x
Siqueira AS, Carvalho MR, Monteiro AC, Freitas VM, Jaeger RG, Pinheiro JJ (2010) Matrix metalloproteinases, TIMPs and growth factors regulating ameloblastoma behaviour. Histopathology 57(1):128–137. https://doi.org/10.1111/j.1365-2559.2010.03596.x
Kim HG, Kim JY, Han EH, Hwang YP, Choi JH, Park BH et al (2011) Metallothionein-2A overexpression increases the expression of matrix metalloproteinase-9 and invasion of breast cancer cells. FEBS Lett 585(2):421–428. https://doi.org/10.1016/j.febslet.2010.12.030
da Rosa MR, Falcão AS, Fuzii HT, da Silva Kataoka MS, Ribeiro AL, Boccardo E et al (2014) EGFR signaling downstream of EGF regulates migration, invasion, and MMP secretion of immortalized cells derived from human ameloblastoma. Tumour Biol 35(11):11107–11120. https://doi.org/10.1007/s13277-014-2401-3
Navarini NF, Araújo VC, Brown AL, Passador-Santos F, Souza IF, Napimoga MH et al (2015) The EGF signaling pathway influences cell migration and the secretion of metalloproteinases by myoepithelial cells in pleomorphic adenoma. Tumour Biol 36(1):205–211. https://doi.org/10.1007/s13277-014-2624-3
Page-McCaw A, Ewald AJ, Werb Z (2007) Matrix metalloproteinases and the regulation of tissue remodelling. Nat Rev Mol Cell Biol 8(3):221–233. https://doi.org/10.1038/nrm2125
Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52–67. https://doi.org/10.1016/j.cell.2010.03.015
Carpenè E, Andreani G, Isani G (2007) Metallothionein functions and structural characteristics. J Trace Elem Med Biol 21(Suppl 1):35–39. https://doi.org/10.1016/j.jtemb.2007.09.011
King JC (2011) Zinc: an essential but elusive nutrient. Am J Clin Nutr 94(2):679S-S684. https://doi.org/10.3945/ajcn.110.005744
Sinduja P, Ramani P, Gheena S, Ramasubramanian A (2020) Expression of metallothionein in oral squamous cell carcinoma: A systematic review. J Oral Maxillofac Pathol 24(1):143–147. https://doi.org/10.4103/jomfp.JOMFP_137_19
Theocharis S, Klijanienko J, Giaginis C, Rodriguez J, Jouffroy T, Girod A et al (2011) Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival. Histopathology 59(3):514–525. https://doi.org/10.1111/j.1365-2559.2011.03947.x
Cherian MG, Jayasurya A, Bay BH (2003) Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat Res 533(1–2):201–209. https://doi.org/10.1016/j.mrfmmm.2003.07.013
Brazão-Silva MT, Rodrigues MF, Eisenberg AL, Dias FL, de Castro LM, Nunes FD et al (2015) Metallothionein gene expression is altered in oral cancer and may predict metastasis and patient outcomes. Histopathology 67(3):358–367. https://doi.org/10.1111/his.12660
Jin R, Chow VT, Tan PH, Dheen ST, Duan W, Bay BH (2002) Metallothionein 2A expression is associated with cell proliferation in breast cancer. Carcinogenesis 23(1):81–86. https://doi.org/10.1093/carcin/23.1.81
Lim D, Jocelyn KM, Yip GW, Bay BH (2009) Silencing the Metallothionein-2A gene inhibits cell cycle progression from G1- to S-phase involving ATM and cdc25A signaling in breast cancer cells. Cancer Lett 276(1):109–117. https://doi.org/10.1016/j.canlet.2008.10.038
Ostrakhovitch EA, Song YP, Cherian MG (2016) Basal and copper-induced expression of metallothionein isoform 1,2 and 3 genes in epithelial cancer cells: The role of tumor suppressor p53. J Trace Elem Med Biol 35:18–29. https://doi.org/10.1016/j.jtemb.2016.01.008
Liu Y, Liu H, Chen W, Yang T, Zhang W (2014) EOLA1 protects lipopolysaccharide induced IL-6 production and apoptosis by regulation of MT2A in human umbilical vein endothelial cells. Mol Cell Biochem 395(1–2):45–51. https://doi.org/10.1007/s11010-014-2110-7
Yap X, Tan HY, Huang J, Lai Y, Yip GW, Tan PH et al (2009) Over-expression of metallothionein predicts chemoresistance in breast cancer. J Pathol 217(4):563–570. https://doi.org/10.1002/path.2489
Werynska B, Pula B, Muszczynska-Bernhard B, Gomulkiewicz A, Piotrowska A, Prus R et al (2013) Metallothionein 1F and 2A overexpression predicts poor outcome of non-small cell lung cancer patients. Exp Mol Pathol 94(1):301–308. https://doi.org/10.1016/j.yexmp.2012.10.006
Liotta LA, Kohn EC (2001) The microenvironment of the tumour-host interface. Nature 411(6835):375–379. https://doi.org/10.1038/35077241
Radisky ES, Radisky DC (2010) Matrix metalloproteinase-induced epithelial-mesenchymal transition in breast cancer. J Mammary Gland Biol Neoplasia 15(2):201–212. https://doi.org/10.1007/s10911-010-9177-x
Grauzam S, Brock AM, Holmes CO, Tiedeken JA, Boniface SG, Pierson BN et al (2018) NEDD9 stimulated MMP9 secretion is required for invadopodia formation in oral squamous cell carcinoma. Oncotarget 9(39):25503–25516. https://doi.org/10.18632/oncotarget.25347
Hong SD, Hong SP, Lee JI, Lim CY (2000) Expression of matrix metalloproteinase-2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 36(2):207–213. https://doi.org/10.1016/s1368-8375(99)00088-3
Piyathilake CJ, Frost AR, Manne U, Weiss H, Bell WC, Heimburger DC et al (2002) Differential expression of growth factors in squamous cell carcinoma and precancerous lesions of the lung. Clin Cancer Res 8(3):734–744
Liao YH, Chiang KH, Shieh JM, Huang CR, Shen CJ, Huang WC et al (2017) Epidermal growth factor-induced ANGPTL4 enhances anoikis resistance and tumour metastasis in head and neck squamous cell carcinoma. Oncogene 36(16):2228–2242. https://doi.org/10.1038/onc.2016.371
Zuo JH, Zhu W, Li MY, Li XH, Yi H, Zeng GQ et al (2011) Activation of EGFR promotes squamous carcinoma SCC10A cell migration and invasion via inducing EMT-like phenotype change and MMP-9-mediated degradation of E-cadherin. J Cell Biochem 112(9):2508–2517. https://doi.org/10.1002/jcb.23175
Singh B, Coffey RJ (2014) From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease. Semin Cell Dev Biol 28:12–21. https://doi.org/10.1016/j.semcdb.2014.03.003
Florence ME, Massuda JY, Soares TC, Stelini RF, Poppe LM, Bröcker EB et al (2015) p53 immunoexpression in stepwise progression of cutaneous squamous cell carcinoma and correlation with angiogenesis and cellular proliferation. Pathol Res Pract 211(10):782–788. https://doi.org/10.1016/j.prp.2015.07.006
Dong C, Wei KJ, Zhang WB, Sun H, Pan HY, Zhang L (2015) LATS2 induced by TNF-alpha and inhibited cell proliferation and invasion by phosphorylating YAP in oral squamous cell carcinoma. J Oral Pathol Med 44(6):475–481. https://doi.org/10.1111/jop.12317
Sasaki T, Hiroki K, Yamashita Y (2013) The role of epidermal growth factor receptor in cancer metastasis and microenvironment. Biomed Res Int 2013:546318. https://doi.org/10.1155/2013/546318
Zulijani A, Dekanić A, Ćabov T, Jakovac H (2021) Metallothioneins and megalin expression profiling in premalignant and malignant oral squamous epithelial lesions. Cancers (Basel) 13(18):4530. https://doi.org/10.3390/cancers13184530
Gioanni J, Fischel JL, Lambert JC, Demard F, Mazeau C, Zanghellini E et al (1988) Two new human tumour cell lines derived from squamous cell carcinomas of the tongue: establishment, characterisation and response to cytotoxic treatment. Eur J Cancer Clin Oncol 24(9):1445–1455. https://doi.org/10.1016/0277-5379(88)90335-5
Aquime JRHS, Zampieri LCDP, Kataoka MSDS, Ribeiro NAB, Jaeger RG, da Silva AL et al (2020) Metallothionein expression and its influence on the in vitro biological behavior of mucoepidermoid carcinoma. Cells 9(1):157. https://doi.org/10.3390/cells9010157
Acknowledgements
Not applicable.
Funding
This research was funded by FAPESPA (Foundation for Research Support of the State of Pará) linked to the State Secretariat for Development, Science and Technology, grant number 006/2016.
Author information
Authors and Affiliations
Contributions
J.J.V.P. and S.M.A.J performed the conceptualization, formal analysis and project administration. M.S.S.K., J.J.V.P. and S.M.A.J. defined the methodology and provided resources. M.S.S.K. and J.J.V.P. validated the project. A.M.D., R.P.M, and R. G. J. performed the investigation and wrote the main manuscript text. A.M.D., J.J.V.P. and S.M.A.J. were responsible for data curation and funding acquisition. All authors reviewed and edited the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest.
Ethical approval
This research was conducted in full accordance with ethical principles and was approved by the Ethics Committee on Research in Human Beings of the Institute of Health Sciences of the Federal University of Pará (Protocol Number 1.593.119).
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Dias, A.M., de Mendonça, R.P., da Silva Kataoka, M.S. et al. Downregulation of metallothionein 2A reduces migration, invasion and proliferation activities in human squamous cell carcinoma cells. Mol Biol Rep 49, 3665–3674 (2022). https://doi.org/10.1007/s11033-022-07206-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11033-022-07206-6